🇬🇧 đŸ‡«đŸ‡·
V

Vaxcyte

Biotechnology Research · United States · 1,000 employees

Biotechnology Research United States B2B Est. 2013
118 Decision makers
+10 New (6 months)
1,000 Employees
2013 Founded

Organizational Chart of Vaxcyte

Roles identified within Vaxcyte's leadership team, from public professional data, updated 25 Oct 2026.

Department

Hiring This department is actively hiring right now.

Vaxcyte's Full Organizational Chart

Loading


Get their contacts on Zeliq →

Job title Department People

Decision makers at Vaxcyte by function

General management

See all Vaxcyte contacts on Zeliq

Decision makers at Vaxcyte

118 identified 5 C-Level 17 VP 96 Directors +10 new (6 months)
See them on Zeliq →

Departments actively hiring 5 departments

Engineering and technical
Finance & accounting
General management
Other
Research

These departments at Vaxcyte are actively recruiting: a strong signal to time your outreach.

Funding and news at Vaxcyte

Funding

Last round Other · $632M
Total funding $4.5B (13 rounds)
Series A $22M Jul 2015
Series B $60M Mar 2017
Series C $85M Jun 2018
Grant $2M Jun 2019
Series D $110M Mar 2020
Grant $3M Dec 2020
Grant $3M Aug 2021
Post-IPO Equity $100M Jan 2022
Post-IPO Equity $600M Oct 2022
Post-IPO Equity $500M Apr 2023
Post-IPO Equity $862M Jan 2024
Post-IPO Equity $1.5B Sep 2024
Post-IPO Equity $632M Jan 2026

Latest news at Vaxcyte

  1. Appointment

    New Director, Immunoassay Development appointed — General management

  2. Appointment

    New Senior Director, Safety & Pharmacovigilance appointed — Medical

  3. Appointment

    New Director Regulatory Cmc appointed — Medical

  4. Appointment

    New Chief Medical Officer appointed — Medical

  5. Appointment

    New Associate Director, Regulatory Cmc appointed — Research

Get these new hires' email and phone →

Team Structure headcount by department

Hiring Research
130
Hiring Other
56
Operations
55
Hiring Technical
55
Hiring General Management
40
Project Management
37
Medical
27
Hiring Finance
26

How to prospect Vaxcyte's departments
Research

First department of the company by headcount (130 people), with hiring underway. Long cycles and rigorous methods: respect their pace and bring evidence, not hype.

Other

A team of 56 people, currently hiring. A cross-functional team where use cases vary: qualify the actual roles before tailoring your pitch.

Technical

This 55-person department is actively recruiting. Technical teams verify claims: public docs, a sandbox or a free tier will do the selling for you.

Operations

This department counts 55 people. Process efficiency and cost control are the angles that resonate with these decision makers.

General Management

Hiring is underway in this team of 40 people. A good executive approach often starts lower in the organisation: build an internal champion before going top-down.

Finance

A team of 26 people, currently hiring. Build your pitch around ROI, payback period and risk reduction: the language this department speaks.

Try the Zeliq email finder demo →

FAQ Vaxcyte

Who runs Vaxcyte?

The highest-ranking leadership role identified at Vaxcyte is “COO”, based on public data updated 25 Oct 2026.

How many decision makers does Vaxcyte have?

118 decision makers identified, including 5 at executive level.

How do I contact a decision maker at Vaxcyte?

Verified emails and phone numbers are available in Zeliq, with free credits at sign-up.

Which departments are hiring at Vaxcyte?

Engineering and technical, Finance & accounting and General management, based on published job offers as of 25 Oct 2026.

Companies similar to Vaxcyte

More companies to explore

Biotechnology Research · United States

All Biotechnology Research companies in United States →

About Vaxcyte

Vaxcyte is a business specialised in Biotechnology Research, based in United States. Established in 2013, it counts about 1,000 employees. As part of the broader Professional Services sector, Vaxcyte operates specifically in the Biotechnology Research segment. Vaxcyte is a B2B company, primarily serving business clients and professional organisations. Vaxcyte has raised funding across 13 rounds totalling $4.5B. This profile compiles key information about Vaxcyte, including industry, size, location, business signals, and B2B contacts, to help sales teams qualify the account and identify the right decision makers before reaching out.

Activity & Market

The company evolves in the Biotechnology Research segment of the Professional Services sector. As a B2B company, Vaxcyte primarily serves business clients and professional organisations. The company is categorised as “Public company”.